Log In
Print
BCIQ
Print
Print this Print this
 

sebelipase alfa (rhLAL) (formerly SBC-102)

  Manage Alerts
Collapse Summary General Information
Company Synageva BioPharma Corp.
DescriptionRecombinant human lysosomal acid lipase (LAL) enzyme replacement therapy (ERT)
Molecular Target
Mechanism of ActionEnzyme replacement therapy
Latest Stage of DevelopmentPhase III
IndicationMetabolic syndrome
Partner

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today